Clinical trial

Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

NCT06620913

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2024-05-01

PhaseN/A

Study timeline

Study start (actual)2024-05-01Date precision: day

Registry last updated2024-10-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

CV2 Autoimmunityunresolved

Interventions

Description of clinical, immunological and tumor features of patients harboring CV2 AbsOTHER

Sponsors & collaborators

Hospices Civils de Lyonlead sponsor

Mapped research locations

BronFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06620913 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.